RMTI
ROCKWELL MEDICAL, INC.
Next earnings Aug 12, 2026 · consensus $-0.03 EPS, $18.2M rev
Last earnings -3.6% on 2026-05-07
$0.65
▲ +0.03%$0.65▼ -25.17%
over 1Y
L $0.62EODHDH $1.83
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+0.0%
1W-2.7%
1M-14.8%
3M-25.2%
YTD-24.6%
1Y-25.2%
Avoid
Conviction
Horizon
Medium (3–12mo)
Street · 8 analysts
Buy
Conservative balance sheet (liabilities/equity 0.55x); but revenue fell -31.8% YoY.
Revenue (FY2025) $69.3M · FY2025
ROCKWELL MEDICAL, INC. shows $69.3M in FY2025 revenue (-31.8% YoY), a -7.7% net margin, and -14.4% ROE.
Financials · annual, by fiscal year
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $61.9M | $72.8M | $83.6M | $101M | $69.3M |
| Gross profit | -$2.42M | $4.08M | $8.70M | $17.5M | $11.7M |
| Operating income | -$30.3M | -$16.8M | -$6.67M | $608K | -$4.69M |
| Net income | -$32.7M | -$18.7M | -$8.44M | -$480K | -$5.31M |
| Diluted EPS | -$3.83 | -$1.31 | -$0.37 | -$0.03 | -$0.15 |
| Net margin | -52.8% | -25.7% | -10.1% | -0.5% | -7.7% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Key statistics
Valuation
Enterprise value$23.8M
EV / EBITDA—
EV / Sales0.3
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield-20.7%
FCF yield-4.7%
Quality & risk
ROIC (est.)-8.1%
Free cash flow-$1.20M
Total debt$8.83M
Net cash$1.89M
Altman Z-Score-7.57 distress
Piotroski F-Score2/9
Capital returns
Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY+15.7%
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Disclosure timeline
SEC · 8-Ks + reportsRed flag in recent filings — delisting notice (2026-05-08). Worth a closer look.
Recent filings
all on EDGAR ↗8-KPeriod ending 2026-06-122026-06-15open ↗DEFA14AFiling2026-05-11open ↗8-KPeriod ending 2026-05-082026-05-08open ↗8-KPeriod ending 2026-05-072026-05-07open ↗10-QPeriod ending 2026-03-312026-05-07open ↗8-KPeriod ending 2026-05-072026-05-07open ↗ARSPeriod ending 2025-12-312026-04-30open ↗DEF 14APeriod ending 2026-04-302026-04-30open ↗PRE 14APeriod ending 2026-04-202026-04-20open ↗4/APeriod ending 2025-05-202026-04-17open ↗4/APeriod ending 2025-05-202026-04-17open ↗4/APeriod ending 2025-05-202026-04-17open ↗
Frequently asked
- Is ROCKWELL MEDICAL, INC. (RMTI) a buy?
- RMTI currently carries a Avoid rating with 4/5 conviction, derived from its latest SEC filings. Conservative balance sheet (liabilities/equity 0.55x); but revenue fell -31.8% YoY.
- What is ROCKWELL MEDICAL, INC.'s quality score?
- RMTI scores 47.3921568627451/100 (grade D) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.
Sources: SEC EDGAR (CIK 0001041024, latest 10-Q filed 2026-05-07) · EODHD · as of 6/26/2026, 4:18:28 AM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.